PND47 CLADRIBINE TABLET, AS A DOMINANT COMPARATOR TO NATALIZUMAB IN HIGH-DISEASE ACTIVITY RELAPSING MULTIPLE SCLEROSIS PATIENTS, IN THE CONTEXT OF A DEVELOPING COUNTRY
Nov 1, 2019, 00:00
10.1016/j.jval.2019.09.1817
https://www.valueinhealthjournal.com/article/S1098-3015(19)34195-6/fulltext
Title :
PND47 CLADRIBINE TABLET, AS A DOMINANT COMPARATOR TO NATALIZUMAB IN HIGH-DISEASE ACTIVITY RELAPSING MULTIPLE SCLEROSIS PATIENTS, IN THE CONTEXT OF A DEVELOPING COUNTRY
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)34195-6&doi=10.1016/j.jval.2019.09.1817
First page :
Section Title :
Open access? :
No
Section Order :
11578